References
- Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288:321–33
- Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1–15
- MacLennan AH, Lester S, Moore V. Oral oestrogen replacement therapy versus placebo for hot flushes (Cochrane Review). In The Cochrane Library 2001, Issue 1. Oxford: Update Software
- Torgerson DJ, Bell-Syer SEM. Hormone replace-ment therapy and prevention of nonvertebral fractures. A meta-analysis of randomized trials. J Am Med Assoc 2001;285:2891–7
- MacLennan AH, Sturdee D. The end of WISDOM. Climacteric 2002;5:313–16
- Greendale GA, Espaland M, Slone S, Marcus R, Barrett-Connor, for the PEPI Safety Follow-up Study Investigators. Bone mass response to discontinuation of long-term hormone replace-ment therapy. Results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Safety Follow-up Study. Arch Intern Med 2002;162: 665–72
- Cranney A, Guyatt G, Griffin L, et al. Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocrine Rev 2002;23: 570–8
- Fleurence R, Torgerson DJ, Reid DM. Cost-effectiveness of hormone replacement therapy for fracture prevention in young postmenopausal women: an economic analysis based on a prospective cohort study. Osteoporos Int 2002; 13:637–43
- Johnell 0, Kanis A, Oden A, Redlund-Johnell I, Hasserius R, Sernbo I, Caulin F. Targeting of hormone replacement therapy immediately after menopause. Bone 2001;28:440–5
- Diamond T. Preventing osteoporotic frac-tures. National Prescribing Service Newsletter [Australia] 2003;26:1–4
- MacLennan AH, Wilson DH, Taylor AW. Hormone replacement therapy use over a decade in an Australian population. Climacteric 2002; 5:351–6
- Steel SA, Albertazzi P, Howarth EM, Purdie DW. Factors affecting long-term adherence to hormone replacement therapy after screening for osteoporosis. Climacteric 2003;6:96–103
- Zandi PP, Carlson MC, Plassman BL, et al. for the Cache County Memory Study Investigators. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. J Am Med Assoc 2002;288: 2123–9
- Naessen T, Lindmark B, Larsen HC. Better postural balance in elderly women receiving estrogens. Am J Obstet Gynecol 1997;177: 412–16
- Berning B, Coelingh Bennink HJ, Fauser BC. Tibolone and its effects on bone: a review. Climacteric 2001;4:120–36